SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced ...
Risk-sharing agreements incentivize high-quality diabetes care by linking reimbursement to value-based outcomes, addressing social determinants of health. Continuous glucose monitoring (CGM) is ...
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired ...
Zacks Investment Research on MSN
VKTX completes enrollment in phase I maintenance study of obesity drug
Viking Therapeutics VKTX announced that it has completed enrolling patients in its exploratory maintenance dosing study of ...
Capivasertib (C) and fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Characterization and management of common adverse events (AEs) ...
In a recent study published in the journal Mindfulness, researchers examine the prevalence and effects of emergent phenomena (EP), their forms, the balance of positive and negative repercussions, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback